Approval by ANVISA Paves the Way for use of UPS Flight from Viracopos Airport
Research Triangle Park, NC, August 21, 2018 – Marken announced today that Brazil’s ANVISA has approved shipments of biological samples from Sao Paulo’s Viracopos airport to the United States using the UPS airline. The pilot program approved by the Brazilian authorities will allow biologic samples to depart from a second Sao Paulo airport to the US, thus allowing Marken to take advantage of an existing UPS flight to any US city. This additional flexibility allows Marken the ability to offer the fastest transit times and best value when compared to other couriers.
The hybrid logistics service leverages the UPS network with Marken’s clinical expertise and benefits Brazil-based clinical investigators by offering a single provider for all shipments. Marken will manage all aspects of the shipment including all investigator orders, export documentation and shipment status updates for full end-to-end visibility.
The new hybrid service extends the latest pick up times for 21 Brazilian cities by up to 5 hours, allowing investigators more time to prepare and package the sample. The use of the UPS aircraft also reduces reliance on commercial airlines, which can offload biologic cargo from time to time leading to shipment delays.
Marken has gradually increased its staff in Brazil due to the continued strong demand from cities in Brazil which are an important source of patients for clinical trials. Additionally, Marken has deployed members of its Mexico operations team to assist with the new service from Brazil, given the success of a similar hybrid service from Mexico City launched a year ago.
Wes Wheeler, Chief Executive Officer, commented on the news: “Brazil becomes the latest country from which we can offer a hybrid transport option to the United States. The new option, which allows use of a second Sao Paulo – based airport at Viracopos provides maximum flexibility for our clients. We can offer later pick-up times, earlier US delivery times and reduced paperwork for investigators in many Brazilian cities. We are the only clinical courier who can offer this level of flexibility and value. We will continue to develop hybrid options for many other cities throughout the world”
Marken is a wholly owned subsidiary of UPS. Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 49 locations worldwide for clinical trial material storage and distribution. Marken’s more than 890 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
CONTACT: Christine Noble, firstname.lastname@example.org, +1 919 474 6890, www.marken.comBack to Index